GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XSWX:BMY) » Definitions » Cyclically Adjusted FCF per Share

Bristol-Myers Squibb Co (XSWX:BMY) Cyclically Adjusted FCF per Share : CHF0.00 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share?

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was CHF1.020. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is CHF0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bristol-Myers Squibb Co's average Cyclically Adjusted FCF Growth Rate was 10.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bristol-Myers Squibb Co was 14.70% per year. The lowest was -1.70% per year. And the median was 7.50% per year.

As of today (2024-05-24), Bristol-Myers Squibb Co's current stock price is CHF44.39. Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was CHF0.00. Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.86. The lowest was 9.12. And the median was 24.17.


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.83 2.15 - - -

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF falls into.



Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.02/131.7762*131.7762
=1.020

Current CPI (Mar. 2024) = 131.7762.

Bristol-Myers Squibb Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.508 100.560 0.666
201409 0.447 100.428 0.587
201412 0.222 99.070 0.295
201503 0.286 99.621 0.378
201506 -0.053 100.684 -0.069
201509 0.168 100.392 0.221
201512 0.354 99.792 0.467
201603 -0.274 100.470 -0.359
201606 0.103 101.688 0.133
201609 0.616 101.861 0.797
201612 0.649 101.863 0.840
201703 0.342 102.862 0.438
201706 0.784 103.349 1.000
201709 0.849 104.136 1.074
201712 0.518 104.011 0.656
201803 0.541 105.290 0.677
201806 0.520 106.317 0.645
201809 0.624 106.507 0.772
201812 1.978 105.998 2.459
201903 0.725 107.251 0.891
201906 1.142 108.070 1.393
201909 1.434 108.329 1.744
201912 0.978 108.420 1.189
202003 1.594 108.902 1.929
202006 1.834 108.767 2.222
202009 0.845 109.815 1.014
202012 1.212 109.897 1.453
202103 1.528 111.754 1.802
202106 1.165 114.631 1.339
202109 2.076 115.734 2.364
202112 1.550 117.630 1.736
202203 1.489 121.301 1.618
202206 0.869 125.017 0.916
202209 1.507 125.227 1.586
202212 1.242 125.222 1.307
202303 1.122 127.348 1.161
202306 0.660 128.729 0.676
202309 1.786 129.860 1.812
202312 1.527 129.419 1.555
202403 1.020 131.776 1.020

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Bristol-Myers Squibb Co  (XSWX:BMY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.86. The lowest was 9.12. And the median was 24.17.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (XSWX:BMY) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.